Adv Healthc Mater:抗菌肽/GO完美解决耐药细菌

2019-09-08 不详 网络

抗菌肽(AMPs)有望从根本上解决耐药细菌的破坏性威胁。然而,AMP的缺点(例如,细胞膜穿透效率差)严重阻碍了其临床应用。本研究中,研究人员实现了蜂毒肽(作为代表性AMP)和石墨烯或氧化石墨烯(Gra或GO)纳米片的混合复合物的合理设计,以增强抗菌能力。检测显示,与原始蜂毒肽相比,特异设计的AMP-Gra(/ GO)复合物在跨膜穿孔中的效率显著提高,肽的阈值工作浓度降低了十倍以上;此外,它对革兰氏

抗菌肽(AMPs)有望从根本上解决耐药细菌的破坏性威胁。然而,AMP的缺点(例如,细胞膜穿透效率差)严重阻碍了其临床应用。本研究中,研究人员实现了蜂毒肽(作为代表性AMP)和石墨烯或氧化石墨烯(Gra或GO)纳米片的混合复合物的合理设计,以增强抗菌能力。

检测显示,与原始蜂毒肽相比,特异设计的AMP-Gra(/ GO)复合物在跨膜穿孔中的效率显著提高,肽的阈值工作浓度降低了十倍以上;此外,它对革兰氏阴性和革兰氏阳性细菌的抗菌活性提高了20倍。这种改善归因于纳米片和蜂毒肽的协同插入,因为它们之间的抗菌机制相似,并且进一步受复合物的结构因素的调节,包括片间距和Gra /GO片的表面功能化等。

总之,这些结果为使用纳米技术设计AMP以提高抗菌性能提供了实用指南,特别是基于Gra/GO纳米片的靶向功能化。

原始出处:

Lu X, Liu J, et al., Designing Melittin-Graphene Hybrid Complexes for Enhanced Antibacterial Activity. Adv Healthc Mater. 2019 May;8(9):e1801521. doi: 10.1002/adhm.201801521. Epub 2019 Mar 13.

评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1861338, encodeId=aa8118613388a, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Wed Aug 12 17:13:00 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724674, encodeId=e4271e2467469, content=<a href='/topic/show?id=808e8040e24' target=_blank style='color:#2F92EE;'>#耐药细菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80407, encryptionId=808e8040e24, topicName=耐药细菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c3133650204, createdName=lingqf, createdTime=Mon Jun 22 06:13:00 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330850, encodeId=05ab133085090, content=<a href='/topic/show?id=c6b455688d1' target=_blank style='color:#2F92EE;'>#抗菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55688, encryptionId=c6b455688d1, topicName=抗菌)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/2898B09F0DA89357D0D54A725E611AC7/100, createdBy=fdd32500040, createdName=ms7899726347904398, createdTime=Tue Sep 10 06:13:00 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621815, encodeId=34c6162181532, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Tue Sep 10 06:13:00 CST 2019, time=2019-09-10, status=1, ipAttribution=)]
    2020-08-12 shizhenshan
  2. [GetPortalCommentsPageByObjectIdResponse(id=1861338, encodeId=aa8118613388a, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Wed Aug 12 17:13:00 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724674, encodeId=e4271e2467469, content=<a href='/topic/show?id=808e8040e24' target=_blank style='color:#2F92EE;'>#耐药细菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80407, encryptionId=808e8040e24, topicName=耐药细菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c3133650204, createdName=lingqf, createdTime=Mon Jun 22 06:13:00 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330850, encodeId=05ab133085090, content=<a href='/topic/show?id=c6b455688d1' target=_blank style='color:#2F92EE;'>#抗菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55688, encryptionId=c6b455688d1, topicName=抗菌)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/2898B09F0DA89357D0D54A725E611AC7/100, createdBy=fdd32500040, createdName=ms7899726347904398, createdTime=Tue Sep 10 06:13:00 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621815, encodeId=34c6162181532, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Tue Sep 10 06:13:00 CST 2019, time=2019-09-10, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1861338, encodeId=aa8118613388a, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Wed Aug 12 17:13:00 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724674, encodeId=e4271e2467469, content=<a href='/topic/show?id=808e8040e24' target=_blank style='color:#2F92EE;'>#耐药细菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80407, encryptionId=808e8040e24, topicName=耐药细菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c3133650204, createdName=lingqf, createdTime=Mon Jun 22 06:13:00 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330850, encodeId=05ab133085090, content=<a href='/topic/show?id=c6b455688d1' target=_blank style='color:#2F92EE;'>#抗菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55688, encryptionId=c6b455688d1, topicName=抗菌)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/2898B09F0DA89357D0D54A725E611AC7/100, createdBy=fdd32500040, createdName=ms7899726347904398, createdTime=Tue Sep 10 06:13:00 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621815, encodeId=34c6162181532, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Tue Sep 10 06:13:00 CST 2019, time=2019-09-10, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1861338, encodeId=aa8118613388a, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Wed Aug 12 17:13:00 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724674, encodeId=e4271e2467469, content=<a href='/topic/show?id=808e8040e24' target=_blank style='color:#2F92EE;'>#耐药细菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80407, encryptionId=808e8040e24, topicName=耐药细菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c3133650204, createdName=lingqf, createdTime=Mon Jun 22 06:13:00 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330850, encodeId=05ab133085090, content=<a href='/topic/show?id=c6b455688d1' target=_blank style='color:#2F92EE;'>#抗菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55688, encryptionId=c6b455688d1, topicName=抗菌)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/2898B09F0DA89357D0D54A725E611AC7/100, createdBy=fdd32500040, createdName=ms7899726347904398, createdTime=Tue Sep 10 06:13:00 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621815, encodeId=34c6162181532, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Tue Sep 10 06:13:00 CST 2019, time=2019-09-10, status=1, ipAttribution=)]